Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment... Show more
Plexus Corp. is a global electronics manufacturing services (EMS) provider serving demanding markets such as Healthcare/Life Sciences, Aerospace/Defense, and Industrial. Its fiscal fourth quarter closes out a pivotal year in which the company accelerated revenue growth well beyond its prior goals, driven by new program ramps and stronger end-market demand. Because Plexus operates on a non-standard fiscal calendar, its fourth quarter ended October 3, 2026, rather than aligning with the calendar year. For investors, this report matters because it confirms whether that momentum is sustainable, how efficiently management is converting higher sales into margins, and whether forward guidance supports continued double-digit expansion heading into fiscal 2027.
Plexus reported fiscal fourth quarter 2026 revenue of $1.427 billion, up from $1.058 billion in the year-ago quarter and above the consensus estimate of roughly $1.36 billion. On a GAAP (Generally Accepted Accounting Principles) basis, diluted EPS was $2.51, while non-GAAP diluted EPS was $2.84, excluding $0.33 of stock-based compensation expense (SBC). The non-GAAP figure beat the $2.55 analyst consensus by approximately 11%.
GAAP operating margin was 6.0% for the quarter, while non-GAAP operating margin reached 6.7%, above the company's guidance range of 6.1% to 6.5%. For the full fiscal year, Plexus reported revenue of $4.965 billion, GAAP diluted EPS of $7.41, and non-GAAP diluted EPS of $8.97. Return on invested capital (ROIC) was 15.8%, producing an economic return of 6.8% above the company's 9.0% weighted average cost of capital.
Management initiated fiscal first quarter 2027 guidance of $1.410 billion to $1.460 billion in revenue, with GAAP diluted EPS of $2.16 to $2.32 and non-GAAP diluted EPS of $2.46 to $2.62. The company also won 36 manufacturing programs representing $290 million in annualized revenue when fully ramped.
Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. By surfacing trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, the tool helps investors narrow their focus and identify setups that match their strategy. Explore the AI Screener to streamline your research and uncover actionable opportunities.
Plexus delivered its results after the market close on October 28, 2026, with a conference call scheduled for the following morning. The quarter's broad beat on both revenue and non-GAAP EPS, combined with guidance above analyst expectations, reinforces a positive sentiment backdrop that has built through fiscal 2026. Investors will be watching closely to see whether the stock extends its recent strength as the market digests the company's upgraded long-term operating margin goal of 6.5% to 7.0%. Key risk factors include customer concentration—top 10 customers comprised 56% of fourth quarter revenue—and the potential for program ramp timing to create quarter-to-quarter volatility.
Plexus enters fiscal 2027 with notable momentum. Management guided first quarter revenue up about 1% sequentially and roughly 34% year over year at the midpoint, and signaled an expectation of mid- to upper-teens revenue growth for the full fiscal year. The company also raised its long-term non-GAAP operating margin target to 6.5% to 7.0%, implying continued focus on operating leverage as revenue scales.
Investors should monitor several items in the quarters ahead. Working capital efficiency remains a priority, with management targeting cash cycle days in the low-to-mid 60s and reiterating an expectation of at least $100 million in fiscal 2027 free cash flow. The company's qualified opportunity funnel expanded by roughly $1.2 billion year over year, reaching a record $4.9 billion, which supports the potential for continued program wins and new customer ramps.
Finally, watch sector-level demand across Healthcare/Life Sciences, Industrial, and Aerospace/Defense, as well as the semiconductor capital equipment subsector, which management has highlighted as a growth driver. Tariff and trade developments, component availability, and customer concentration remain the primary variables that could influence the pace of expansion.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of electronic manufacturing services
Industry ElectronicComponents